GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Total Liabilities (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Total Liabilities came in at $18.3 million in Q2 2026, down 38.44% on a YoY basis from $29.7 million in Q2 2025, and down 7.36% quarter-over-quarter from $19.7 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Total Liabilities (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Total Liabilities for 12 consecutive years, with $18.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Liabilities fell 38.44% year-over-year to $18.3 million; the trailing twelve-month figure through Jun 2026 stood at $18.3 million (down 38.44% YoY), and the FY2025 full-year result was $19.7 million, down 28.57% from the prior year.
  • Total Liabilities slipped to $18.3 million in Q2 2026 per GRDX's latest filing, from $19.7 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $45.8 million in Q3 2025 and bottomed at $2.6 million in Q3 2023.
  • Historically, Total Liabilities has averaged $16.0 million across 5 years, with a median of $15.8 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Total Liabilities sank 86.25% in 2022, then surged 741.55% in 2024.
  • Over 5 years, Total Liabilities stood at $2.7 million in 2022, then grew by 21.6% to $3.3 million in 2023, then soared by 741.55% to $27.6 million in 2024, then declined by 28.57% to $19.7 million in 2025, then declined by 7.36% to $18.3 million in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods registered $18.3 million, $19.7 million, and $45.8 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 83.95 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 37.53 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 7.18 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 10.02 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.62 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 4.20 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 4.20 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 13.24 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 384.62 Mn
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 18.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18.27 Mn
Dec 31, 2025 19.72 Mn
Sep 30, 2025 45.81 Mn
Jun 30, 2025 29.68 Mn
Mar 31, 2025 28.74 Mn
Dec 31, 2024 27.61 Mn
Sep 30, 2024 15.77 Mn
Jun 30, 2024 15.49 Mn
Mar 31, 2024 13.27 Mn
Dec 31, 2023 3.28 Mn
Sep 30, 2023 2.65 Mn
Jun 30, 2023 3.45 Mn
Mar 31, 2023 2.82 Mn
Dec 31, 2022 2.70 Mn
Sep 30, 2022 6.93 Mn
Jun 30, 2022 18.12 Mn
Mar 31, 2022 18.07 Mn
Dec 31, 2021 19.61 Mn
Sep 30, 2021 19.39 Mn
Jun 30, 2021 6.74 Mn